Who owns Orexigen Therapeutics?

Key details on Orexigen Therapeutics (Ticker: OREX)

Who owns Orexigen Therapeutics?

Is OREX a good stock to own? Find out who bought Orexigen Therapeutics, who sold Orexigen Therapeutics (OREX) stock, and who holds a large position in Orexigen Therapeutics.

Fund Name Number of Shares Share Valuation As Of
STATE STREET CORPORATION 11.78M $24.86M Sept. 30, 2015
FMR 11.60M $19.95M Dec. 31, 2015
T. Rowe Price Associates 6.51M $11.19M Dec. 31, 2015
Foresite Capital Management II 6.23M $10.71M Dec. 31, 2015
Samlyn Capital 6.16M $10.60M Dec. 31, 2015
Vanguard 6.06M $10.42M Dec. 31, 2015
QVT Financial 5.12M $7.43M Dec. 31, 2011
BlackRock Fund Advisors 4.45M $7.65M Dec. 31, 2015
Franklin Resources 4.32M $7.44M Dec. 31, 2015
S.A.C. Capital Advisors 4.30M $24.20M Dec. 31, 2013
NEA Management Company 3.71M $6.38M Dec. 31, 2015
Capital Research Global Investors^ 3.62M $28.34M March 31, 2015
Millennium Management 3.49M $6.00M Dec. 31, 2015
MORGAN STANLEY 3.30M $5.71M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 3.19M $5.49M Dec. 31, 2015
Foresite Capital Management III 3.00M $5.16M Dec. 31, 2015
Scale Management 2.88M $22.58M March 31, 2015
Deutsche Bank Aktiengesellschaft 2.88M $6.08M Sept. 30, 2015
Partner Fund Management 2.87M $22.48M March 31, 2015
FIRST MANHATTAN 2.81M $17.37M June 30, 2014
Renaissance Technologies 2.78M $5.87M Sept. 30, 2015
Farallon Capital Management 2.68M $17.45M March 31, 2014
Bank of America Corporation 2.57M $10.96M Sept. 30, 2014
SUSQUEHANNA INTERNATIONAL 2.53M $10.77M Sept. 30, 2014
Credit Suisse AG 2.48M $4.26M Dec. 31, 2015